戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 count for PV and non-PV group differences in baseline characteristics.
2 a sodium measurements, together with patient baseline characteristics.
3      Patients in the 2 groups had comparable baseline characteristics.
4 onsiderably worse survival, independently of baseline characteristics.
5  subgroups, identified on the basis of their baseline characteristics.
6 inating in-hospital mortality, adjusting for baseline characteristics.
7 rative data sources were used to control for baseline characteristics.
8 hed cohort, with adjustment for more than 90 baseline characteristics.
9           Thirty-day death was modeled using baseline characteristics.
10 life years, respectively while adjusting for baseline characteristics.
11 ; patients were propensity score matched for baseline characteristics.
12 th males is related mainly to differences in baseline characteristics.
13 ke cases, with no significant differences in baseline characteristics.
14 as also performed to minimize confounding by baseline characteristics.
15 are tests to examine race differences in the baseline characteristics.
16 ching was used to correct for differences in baseline characteristics.
17 black and white patients after adjusting for baseline characteristics.
18 sed instead of multivariable adjustments for baseline characteristics.
19 e <70 versus >/=70 beats/min, balanced on 58 baseline characteristics.
20 nsity within 28 days in an adjusted model of baseline characteristics.
21   The 2 groups were well-matched in terms of baseline characteristics.
22  The 2 groups were well balanced in terms of baseline characteristics.
23 t patients significantly after adjusting for baseline characteristics.
24 except sudden death in a model including all baseline characteristics.
25  to account for between-trial differences in baseline characteristics.
26         Responses were similar regardless of baseline characteristics.
27 ection that were well-matched with regard to baseline characteristics.
28 tment, data collection, lessons learned, and baseline characteristics.
29 t but not associated with any other measured baseline characteristics.
30 roups in the trial were very similar on most baseline characteristics.
31  to that of non-EVLP recipients with similar baseline characteristics.
32 irs of patients was assembled balanced on 74 baseline characteristics.
33 ropensity score overlap weighting to balance baseline characteristics.
34 e groups after adjustment for differences in baseline characteristics.
35 FLR <=30% and >30% were matched 1:2 based on baseline characteristics.
36 dabigatran, rivaroxaban, and warfarin) on 66 baseline characteristics.
37 are tests to examine race differences in the baseline characteristics.
38 ation of recipients with the most overlap in baseline characteristics.
39  for repeated measurement accounting for key baseline characteristics.
40 tients with proteinuria after adjustment for baseline characteristics.
41                   The two groups had similar baseline characteristics.
42 er adjustment for other health behaviors and baseline characteristics 0.56 (95% confidence interval [
43 ations between FVC/TLC(CT) quartiles and (1) baseline characteristics, (2) respiratory exacerbations,
44                            After matching on baseline characteristics, 20 918 patients were analyzed
45                                              Baseline characteristics, 30-day to 1-year all-cause mor
46                            After matching on baseline characteristics, 717 patients were analyzed in
47 r mixed-effects models assessed relations of baseline characteristics, acuity (at birth, across hospi
48                                              Baseline characteristics, acuity, morbidity, and nutriti
49                                  Data on how baseline characteristics, acuity, morbidity, and nutriti
50 population with no significant difference in baseline characteristics (age, 79+/-8.2 years; 60% women
51                        Information regarding baseline characteristics, all-cause mortality, and readm
52         The two groups had generally similar baseline characteristics, although diabetes and peripher
53 t weighting was used to balance more than 60 baseline characteristics among patients in the 4 drug co
54                                              Baseline characteristics among patients with nonshockabl
55                                              Baseline characteristics, anatomic SYNTAX score, number
56 ciation between CTG expansion size and other baseline characteristics and (1) cardiac involvement at
57  models that accounted for variations in (1) baseline characteristics and (2) both baseline and surgi
58 isson regression models were used to compare baseline characteristics and 1:1 propensity score-matche
59 y-six patients were eligible for analysis of baseline characteristics and 3259 for recurrence outcome
60     Patient charts were reviewed to identify baseline characteristics and anti-VEGF treatment details
61  method to ascertain the association between baseline characteristics and cardiovascular mortality.
62 ncluded to evaluate selection criteria used, baseline characteristics and clinical outcomes at 3-mont
63                                              Baseline characteristics and clinical outcomes of partic
64                                              Baseline characteristics and clinical outcomes of patien
65                     Sex-based differences in baseline characteristics and clinical outcomes were asse
66 tween January and June 2012 were studied for baseline characteristics and clinical outcomes.
67 subgroups that differed significantly in all baseline characteristics and clinical trajectories, desp
68  patients, particularly examining effects of baseline characteristics and CLL-directed therapy, is cr
69 n vitamin D sufficiency after adjustment for baseline characteristics and concurrent graft function a
70 ortality hazard ratios after controlling for baseline characteristics and disease severity.
71                                              Baseline characteristics and factors on treatment were a
72 tched to nonexposed controls (n = 76 825) by baseline characteristics and gestational age.
73 for baseline characteristics and score 2 for baseline characteristics and ICU management.
74                                  We compared baseline characteristics and infection incidence rates b
75                                              Baseline characteristics and infectious diagnoses were s
76                                  We describe baseline characteristics and long-term follow-up in pati
77                                              Baseline characteristics and maintenance immunosuppressi
78                                              Baseline characteristics and mean tacrolimus trough leve
79                                              Baseline characteristics and medication use were compare
80 nd identification of the association between baseline characteristics and occurence structural progre
81       This retrospective study describes the baseline characteristics and outcome data of COVID-19 in
82                              We compared the baseline characteristics and outcomes between patients r
83 bstracts for observational studies comparing baseline characteristics and outcomes in patients with N
84                    We aimed to establish the baseline characteristics and outcomes of paediatric pati
85                                    We report baseline characteristics and outcomes of the first 2,000
86                                              Baseline characteristics and outcomes were compared.
87                                              Baseline characteristics and overall survival were compa
88 allic DES and could be determined by patient baseline characteristics and periprocedural factors.
89  poor platelet recovery after adjustment for baseline characteristics and platelet transfusion.
90      Univariate analysis was used to compare baseline characteristics and postoperative outcomes.
91 D compared with those without, adjusting for baseline characteristics and postprocedure medications.
92           We studied the association between baseline characteristics and rates of cardiovascular dea
93 versus medical management, regardless of all baseline characteristics and rhythm (adjusted hazard rat
94                                              Baseline characteristics and risk categories were well b
95                Propensity score matching for baseline characteristics and risk factors for death and
96  to control for between-group differences in baseline characteristics and risk.
97 tained for consecutive matching, score 1 for baseline characteristics and score 2 for baseline charac
98                     Models were adjusted for baseline characteristics and severity of illness.
99 -only versus balloon-stent group had similar baseline characteristics and similar incidence of target
100 ssion was used to study associations between baseline characteristics and the occurrence of structura
101 ant associations were identified between any baseline characteristics and time to ART initiation or c
102 hage (ICH) and whether it is modified by key baseline characteristics and timing remains uncertain.
103                     Groups were compared for baseline characteristics and total kidney volume (TKV) g
104 ealth-data registers was performed to obtain baseline characteristics and vital status.
105 olled patients were included in demographic, baseline characteristics, and safety analyses.
106                               To investigate baseline characteristics associated with 6-month VA and
107                                              Baseline characteristics associated with an increased ri
108 ncer, and RRs with 95% CIs were adjusted for baseline characteristics associated with availability of
109 able regression models were used to identify baseline characteristics associated with remission overa
110                                              Baseline characteristics at first visit were used as pre
111                                  We compared baseline characteristics at listing and at HT and used C
112                         After adjustment for baseline characteristics, AVR+ARE was not associated wit
113                 There were no differences in baseline characteristics between groups with and without
114                 There were no differences in baseline characteristics between groups.
115 robability of treatment weighting to balance baseline characteristics between groups.
116    There were significant differences in the baseline characteristics between non-Hispanic AA and non
117    There were significant differences in the baseline characteristics between non-Hispanic African Am
118 count for observed systematic differences in baseline characteristics between patients treated and th
119 There were no significant differences in the baseline characteristics between the DSA- MVI and DSA+ A
120 ial regression, adjusting for the imbalanced baseline characteristics between the groups.
121                               Differences in baseline characteristics between those who did and did n
122                However, after adjustment for baseline characteristics, black (adjusted odds ratio = 0
123 ska Native patients; but after adjusting for baseline characteristics, black race and Hispanic ethnic
124                                              Baseline characteristics, blood samples, and angiography
125 ients with and without aHG did not differ in baseline characteristics both in the non-DM (n = 12,318)
126 with standardized protocols and adjusted for baseline characteristics by Cox regression.
127                                              Baseline characteristics can be used to predict subseque
128                                  We compared baseline characteristics, clinical courses, and therapie
129 ther there is an association between SES and baseline characteristics, clinical outcomes and use of s
130                                              Baseline characteristics, clinical presentation, antivir
131                                              Baseline characteristics, comorbidities, utilization, an
132                After adjustment for multiple baseline characteristics, compared with no-VHD patients
133 propensity score matching, no differences in baseline characteristics could be observed.
134                                              Baseline characteristics, data on management and geriatr
135                                          The baseline characteristics, development of early dermatolo
136                                              Baseline characteristics did not differ between the rand
137                                              Baseline characteristics did not differ between these pa
138                                          The baseline characteristics did not differ significantly be
139                                              Baseline characteristics differed in patients with LVEDV
140                                              Baseline characteristics, duration of heparin treatment,
141 fficacy International Trial and adjusted for baseline characteristics during 6 years' median follow-u
142 eir infants and who were closely matched for baseline characteristics (e.g., parity, body composition
143 4 hours of shock onset, after accounting for baseline characteristics, etiology and location of shock
144               Here, we present participants' baseline characteristics, examining clinical and demogra
145                                      Data on baseline characteristics, first-line treatment, treatmen
146                                              Baseline characteristics following stratification, inclu
147      Shape-descriptive factors and patients' baseline characteristics had significant prognostic valu
148                                              Baseline characteristics, hepatitis C viral load (VL), g
149 ical ventilation patients and compared their baseline characteristics, hospital events, and hospital
150 djusted life years according to all assessed baseline characteristics (ICU admission after elective s
151                    Multivariable analysis of baseline characteristics identified high marrow tumor bu
152 gy Diary users were able to properly provide baseline characteristics (ii) simple phenotypic characte
153  bleeding in the 1-year mortality model with baseline characteristics improved it to an extent compar
154  CIs were estimated controlling for over 140 baseline characteristics in each data source and pooled
155 patients with cardiogenic shock with similar baseline characteristics in New York and Michigan.
156  3374 pairs after propensity score matching; baseline characteristics in the matched cohort were well
157                                       Median baseline characteristics included age 36 years (IQR 30-4
158                                              Baseline characteristics including LOAELs were comparabl
159                                              Baseline characteristics including median age (71 and 68
160                                              Baseline characteristics including prescribed antibiotic
161                                              Baseline characteristics (including biomarkers and quali
162               Both groups were comparable in baseline characteristics, including age, preoperative IO
163                                              Baseline characteristics, including AKI stage and sepsis
164                   Propensity matching for 16 baseline characteristics, including diagnosis, yielded 1
165 vs 35%; p < 0.05), but otherwise had similar baseline characteristics, including initial cardiac rhyt
166               Both groups were comparable in baseline characteristics, including IOP and total laser
167  for EDS was generated, which included seven baseline characteristics, including non-motor symptoms a
168  treated with FMT versus antibiotics in many baseline characteristics, including number of recurrence
169                                              Baseline characteristics, including severity of pain and
170                                              Baseline characteristics, lead locations and stimulation
171                            Following patient baseline characteristics matching across clinical trials
172 ort of 698 pairs of patients, balanced on 50 baseline characteristics (mean age 76 years; mean EF 28%
173  SBP <130 versus >=130 mm Hg, balanced on 58 baseline characteristics (mean age 76 years; mean EF 28%
174                              We adjusted the baseline characteristics, medical treatment, and drug ad
175 ltivariate regression models including urban baseline characteristics, meteorological variables, and
176                     We then assessed whether baseline characteristics moderated the intervention's ef
177                                              Baseline characteristics, MSNA and haemodynamics were si
178                                              Baseline characteristics of 984 patients with LF AS incl
179                                              Baseline characteristics of admitted patients with COVID
180 w-up through December 31, 2015, compared the baseline characteristics of AYA (13-39 years old) and OA
181                                          The baseline characteristics of both groups were comparable.
182 onfounders due to unbalanced distribution of baseline characteristics of HIV/HCV-coinfected and HCV-m
183 s on protein structure and function, and the baseline characteristics of indels in 2504 individuals o
184 en baseline and month 6 were correlated with baseline characteristics of loci using regression models
185                   To describe the design and baseline characteristics of participants in the Study of
186                              We examined the baseline characteristics of patients by change in sympto
187             There were no differences in the baseline characteristics of patients enrolled in the ext
188         The aim of this study was to compare baseline characteristics of patients receiving intravitr
189                                          The baseline characteristics of patients seen by each provid
190 ysis and network-based statistics to explore baseline characteristics of patients who subsequently re
191  an in-depth genotype-phenotype study of the baseline characteristics of patients with CMT2A and long
192                                              Baseline characteristics of patients with regard to the
193 nte di Legno group, we collected data on the baseline characteristics of patients, including IKZF1, P
194                                              Baseline characteristics of patients, interventions, and
195                                          The baseline characteristics of the 2 treatment arms were si
196 f the Offspring Study and presented selected baseline characteristics of the cohort.
197                                              Baseline characteristics of the groups were similar.
198          After adjustment for changes in the baseline characteristics of the infants over time, both
199                          The demographic and baseline characteristics of the participants were simila
200  luspatercept and 76 to receive placebo; the baseline characteristics of the patients were balanced.
201                          Similarities of the baseline characteristics of the SCORE2 population to oth
202                               After matching baseline characteristics of the SOLVD clinical study, pa
203 However, in biomedical data, there are often baseline characteristics of the subjects in a study or b
204                                          The baseline characteristics of the two groups were similar.
205                              We describe the baseline characteristics of the VANISH cohort and compar
206            In a multivariate model including baseline characteristics, only receiving a disability gr
207               Subgroup analysis according to baseline characteristics or strata of traditional cardio
208                   There was no difference in baseline characteristics or venous thromboembolism event
209                        Little is known about baseline characteristics or ventilator strategies that m
210                                              Baseline characteristics, outcomes, risk factors, and ad
211 ears post-diagnosis and independently of all baseline characteristics (p values <0.0001).
212                         After adjustment for baseline characteristics, patients enrolled based on pre
213                         After adjustment for baseline characteristics, patients enrolled based on pre
214                        After adjustments for baseline characteristics, patients in the systematic str
215  response at treatment end; and (3) identify baseline characteristics predicting an early nonresponse
216 were additionally adjusted for age and other baseline characteristics predicting treatment risk.
217 d trazodone to that of patients with similar baseline characteristics prescribed other antidepressant
218                                              Baseline characteristics, presentations, comorbid condit
219 l situation in which 2 patients with similar baseline characteristics receive a kidney transplant on
220 es and whether heterogeneity is based on key baseline characteristics remains undefined.
221             Our objective was to compare the baseline characteristics, resources, and treatments with
222                            Graft and patient baseline characteristics, risk factors for failure, surg
223                                              Baseline characteristics, SD OCT measurements, and preop
224                        None of the patients' baseline characteristics (shock, use of angiotensin-conv
225                                     No other baseline characteristics significantly predicted success
226                                  We compared baseline characteristics, social determinants of health,
227 2 factorial design minimizing differences in baseline characteristics such as age, sex, and duration
228                                              Baseline characteristics, such as young age, male sex, a
229  greater impact on NO2 and PM2.5 change than baseline characteristics, suggesting urban design and la
230 d December 2005, 9792 patients with complete baseline characteristics, surgery procedure, and follow-
231                                              Baseline characteristics that include prescribed antibio
232                                              Baseline characteristics that were examined included dem
233              After adjustment for unbalanced baseline characteristics, the hazard ratio for being dis
234                         After adjustment for baseline characteristics, the results remained essential
235                         After accounting for baseline characteristics, the risk of death remained hig
236                         After accounting for baseline characteristics, there was a similar incidence
237                         After adjustment for baseline characteristics, those with evidence of kidney
238                                 We collected baseline characteristics, time of syncope and ED arrival
239                                              Baseline characteristics, time to failure or last visit,
240 AG patients were propensity matched using 38 baseline characteristics to reduce selection bias.
241 resection after adjusting for differences in baseline characteristics using propensity score analysis
242                                   To compare baseline characteristics, visual acuity (VA) and morphol
243                                              Baseline characteristics, visual acuity (VA) at 5 years,
244                 Propensity score matching by baseline characteristics was performed for patients with
245                                Adjusting for baseline characteristics, we found no difference in risk
246                                              Baseline characteristics were balanced across treatments
247                                              Baseline characteristics were balanced between the 2 gro
248                                              Baseline characteristics were balanced between the two a
249                                              Baseline characteristics were balanced between the two g
250 lled (Ona + Bev, n = 64; Pla + Bev, n = 65), baseline characteristics were balanced.
251                                              Baseline characteristics were collected to identify the
252                                              Baseline characteristics were collected to tabulate MAGG
253                                              Baseline characteristics were comparable across treatmen
254                                              Baseline characteristics were comparable across years.
255                                              Baseline characteristics were comparable between groups,
256                                              Baseline characteristics were comparable between groups,
257                                              Baseline characteristics were comparable by arm.
258 s (55% treated pooled vs 25% placebo); other baseline characteristics were comparable.
259                                              Baseline characteristics were compared between the 2 gro
260 sed the risk of transformation or death when baseline characteristics were considered with a hazard r
261 spital volume was divided into 3 groups, and baseline characteristics were described.
262                                              Baseline characteristics were determined from administra
263 servational studies that did not control for baseline characteristics were excluded, catheter-related
264                                              Baseline characteristics were generally comparable betwe
265                                              Baseline characteristics were not different between gend
266 phics, clinical characteristics, and imaging baseline characteristics were presented by descriptive s
267 pleted accrual and 206 patients with similar baseline characteristics were randomized 1:1 to the two
268                                              Baseline characteristics were similar across cohorts.
269                                              Baseline characteristics were similar across groups and
270                                              Baseline characteristics were similar among groups.
271                                              Baseline characteristics were similar and representative
272                                              Baseline characteristics were similar between 571 interv
273                                              Baseline characteristics were similar between all partic
274                                              Baseline characteristics were similar between FIX-HF-5C
275                                              Baseline characteristics were similar between groups.
276             In the ILLUMENATE Pivotal Study, baseline characteristics were similar between groups: 50
277                                              Baseline characteristics were similar between the 2 grou
278                                              Baseline characteristics were similar between the groups
279                                              Baseline characteristics were similar between the halope
280                                              Baseline characteristics were similar between treatment
281                                              Baseline characteristics were similar except for mean do
282                                              Baseline characteristics were similar in both groups.
283                                              Baseline characteristics were similar in both zoledronic
284                                              Baseline characteristics were similar in the early (n =
285                                              Baseline characteristics were similar in the interventio
286                                              Baseline characteristics were similar in the interventio
287                                              Baseline characteristics were similar in the patients tr
288                                              Baseline characteristics were similar in the two cohorts
289                                              Baseline characteristics were similar in the two groups;
290                                              Baseline characteristics were similar, except more men (
291                                Between-group baseline characteristics were similar.
292                                              Baseline characteristics were well balanced among sub-co
293                                      Results Baseline characteristics were well balanced among the ar
294                                              Baseline characteristics were well balanced between stud
295                      Patient demographic and baseline characteristics were well balanced between the
296   Despite variation in indications for GPIs, baseline characteristics were well balanced between the
297 e DES- and BMS-treated groups whose observed baseline characteristics were well-balanced.
298         Women and men present with different baseline characteristics, which may influence procedural
299                               Association of baseline characteristics with failure to cure was analyz
300  we extracted the most recent measurement of baseline characteristics (within 2 years of diagnosis) f

 
Page Top